ARIAD Pharmaceuticals Inc. develops breakthrough medicines that regulate cell-signaling pathways implicated in cancer. The company’s pipeline includes a series of small molecule product candidates that provide targeted and highly potent anti-cancer activity to treat solid tumors and hematologic cancers, as well as the metastatic spread of tumors.